Mesh Selection in Abdominal Wall Reconstruction

Lak, Kathleen; Goldblatt, Matthew I.

doi:10.1097/prs.0000000000004862

Cited by 23 publications

(16 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite numerous graft options and the frequent creation of novel technologies to address hernia-related issues, the optimal solution to the challenges surrounding infectious graft-related complications remains unclear. 26-31…”

Section: Discussionmentioning

confidence: 99%

Long-Term Clinical Outcomes of an Antibiotic-Coated Non–Cross-linked Porcine Acellular Dermal Graft for Abdominal Wall Reconstruction for High-Risk and Contaminated Wounds

Robinson

Motz

et al. 2021

The American Surgeon

View full text Add to dashboard Cite

Background Abdominal wall reconstruction in high-risk and contaminated cases remains a challenging surgical dilemma. We report long-term clinical outcomes for a rifampin-/minocycline-coated acellular dermal graft (XenMatrix™ AB) in complex abdominal wall reconstruction for patients with a prior open abdomen or contaminated wounds. Methods Patients undergoing abdominal wall reconstruction at our institution at high risk for surgical site occurrence and reconstructed with XenMatrix™ AB with intent-to-treat between 2014 and 2017 were included. Demographics, operative characteristics, and outcomes were collected. The primary outcome was hernia recurrence. The secondary outcomes included length of stay, surgical site occurrence, readmission, morbidity, and mortality. Results Twenty-two patients underwent abdominal wall reconstruction using XenMatrix™ AB during the study period. Two patients died while inpatient from progression of their comorbid diseases and were excluded. Sixty percent of patients had an open abdomen at the time of repair. All patients were from modified Ventral Hernia Working Group class 2 or 3. There were a total of four 30-day infectious complications including superficial cellulitis/fat necrosis (15%) and one intraperitoneal abscess (5%). No patients required reoperation or graft excision. Median clinical follow-up was 38.2 months with a mean of 35.2 +/− 18.5 months. Two asymptomatic recurrences and one symptomatic recurrence were noted during this period with one planning for elective repair of an eventration. Follow-up was extended by phone interview which identified no additional recurrences at a median of 45.5 and mean of 50.5 +/−12.7 months. Conclusion We present long-term outcomes for patients with high-risk and contaminated wounds who underwent abdominal wall reconstruction reinforced with XenMatrix™ AB to achieve early, permanent abdominal closure. Acceptable outcomes were noted.

show abstract

Section: Discussionmentioning

confidence: 99%

Long-Term Clinical Outcomes of an Antibiotic-Coated Non–Cross-linked Porcine Acellular Dermal Graft for Abdominal Wall Reconstruction for High-Risk and Contaminated Wounds

Robinson

Motz

et al. 2021

The American Surgeon

View full text Add to dashboard Cite

show abstract

“…Identifying the optimal mesh for abdominal wall reconstruction can be an overwhelming task [15] . Selection of a permanent synthetic mesh may have improved long term hernia prevention without increased infectious concerns [16] , [17] .…”

Section: Discussionmentioning

confidence: 99%

Report of novel application of T-line hernia mesh in ventral hernia repair

Hollins

Levinson

2022

International Journal of Surgery Case Reports

View full text Add to dashboard Cite

“…SMs used for replacement and reconstruction of the abdominal wall such as polytetrafluorethylene, polyester, and polypropylene are well established. However, they are being reported for provoking unwanted adhesions, fistula formations, and sincere wound infections . In addition, SMs are associated with mesh contraction, chronic pain, inflammation, and seroma .…”

Section: Discussionmentioning

confidence: 99%

Outcome after pediatric liver transplantation for staged abdominal wall closure with use of biological mesh—Study with long‐term follow‐up

Gül‐Klein

Dziodzio

Martin

et al. 2020

Pediatric Transplantation

View full text Add to dashboard Cite

Abdominal wall closure after pediatric liver transplantation (pLT) in infants may be hampered by graft‐to‐recipient size discrepancy. Herein, we describe the use of a porcine dermal collagen acellular graft (PDCG) as a biological mesh (BM) for abdominal wall closure in pLT recipients. Patients <2 years of age, who underwent pLT from 2011 to 2014, were analyzed, divided into definite abdominal wall closure with and without implantation of a BM. Primary end‐point was the occurrence of postoperative abdominal wall infection. Secondary end‐points included 1‐ and 5‐year patient and graft survival and the development of abdominal wall hernia. In five out of 21 pLT recipients (23.8%), direct abdominal wall closure was achieved, whereas 16 recipients (76.2%) received a BM. BM removal was necessary in one patient (6.3%) due to abdominal wall infection, whereas no abdominal wall infection occurred in the no‐BM group. No significant differences between the two groups were observed for 1‐ and 5‐year patient and graft survival. Two late abdominal wall hernias were observed in the BM group vs none in the no‐BM group. Definite abdominal wall closure with a BM after pLT is feasible and safe when direct closure cannot be achieved with comparable postoperative patient and graft survival rates.

show abstract

Mesh Selection in Abdominal Wall Reconstruction

Cited by 23 publications

References 34 publications

Long-Term Clinical Outcomes of an Antibiotic-Coated Non–Cross-linked Porcine Acellular Dermal Graft for Abdominal Wall Reconstruction for High-Risk and Contaminated Wounds

Long-Term Clinical Outcomes of an Antibiotic-Coated Non–Cross-linked Porcine Acellular Dermal Graft for Abdominal Wall Reconstruction for High-Risk and Contaminated Wounds

Report of novel application of T-line hernia mesh in ventral hernia repair

Outcome after pediatric liver transplantation for staged abdominal wall closure with use of biological mesh—Study with long‐term follow‐up

Contact Info

Product

Resources

About